Format

Send to

Choose Destination
Expert Rev Hematol. 2012 Oct;5(5):505-11; quiz 512. doi: 10.1586/ehm.12.42.

Hypercoagulability in β-thalassemia: a status quo.

Author information

1
Department of Internal Medicine, IRCCS Ca' Granda Foundation Maggiore Policlinico Hospital, University of Milan, Milan, Italy. maria.cappellini@unimi.it

Abstract

Life expectancy of thalassemia patients has markedly improved over the last few decades, but patients still suffer from many complications of their congenital chronic disease, and several new complications are now being acknowledged, including thrombosis. The high prevalence of thromboembolic events, especially in thalassemia intermedia, has led to the identification of a hypercoagulable state in these patients. This review summarizes current knowledge of the clinical and pathophysiological characteristics of hypercoagulability in thalassemia patients. Strategies to prevent thrombotic events are also discussed.

PMID:
23146054
DOI:
10.1586/ehm.12.42
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center